scispace - formally typeset
J

Javier C. Angulo

Researcher at European University of Madrid

Publications -  436
Citations -  6847

Javier C. Angulo is an academic researcher from European University of Madrid. The author has contributed to research in topics: Cancer & Prostate cancer. The author has an hindex of 36, co-authored 413 publications receiving 5834 citations. Previous affiliations of Javier C. Angulo include University of Alcalá & Wayne State University.

Papers
More filters
Journal ArticleDOI

Original articleThe role of matrix metalloproteinase MMP-9 and TIMP-2 tissue inhibitor of metalloproteinasas as serum markers of bladder cancerEl papel de la metaloproteinasa de la matriz MMP-9 y del inhibidor tisular de metaloproteinasa TIMP-2 como marcadores séricos de cáncer vesical☆

TL;DR: The results obtained suggest that both serum MMP-9 and TIMP-2 would have an application in the prediction of the development and progression of bladder cancer, and a potential utility as clinical markers of the disease.
Journal ArticleDOI

Topical dobesilate eye drops for ophthalmic primary pterygium.

TL;DR: Selective inhibition of fibroblast growth factor and vascular endothelial growth factor signalling pathways is effective in causing regression of pterygia and the authors believe that this is the first known successful use of topical dobesilate in primary pteryGium.
Journal ArticleDOI

Impact of p53, MIB-1 and PECAM-1 expression on the prognosis of urothelial carcinoma of the renal pelvis.

TL;DR: Histological grade, tumor growth pattern and p53 overexpression were established as the primary predictors of prognosis for primary TCC-UUT of the renal pelvis.
Journal ArticleDOI

A DNA Hypermethylation Profile Independently Predicts Biochemical Recurrence Following Radical Prostatectomy

TL;DR: Epigenetic silencing of GSTM2 and MYCL2 comprise novel molecular markers to predict BCR after surgery for medium- and high-risk localized PCa undergoing surgical treatment and hypermethylation of these genes could be incorporated to the clinical and pathological factors defining the patient at higher risk of PSA failure after prostatectomy.
Journal ArticleDOI

Consenso experto sobre la evidencia científica disponible acerca del uso de toxina botulínica en vejiga hiperactiva

TL;DR: Los panelistas consideran that puede plantearse una modificacion en the definicion actual of VH, and that parece necesario mejorar las herramientas de cribado.